NPI registry status
Active
2026 NPPES data Neurology Physician NPI 1902891104 M.D.
Verify on CMS → Paulo Cancado, M.D.
Neurology Physician in Kennewick, Washington.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 19,866 in Neurology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 326 beneficiaries · Neurology Physician avg: 1K
Generic prescribing
93%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
88.4/100
▲ 5 pts above national avg 83.1 · Above neutral
Industry payments
$60.35
4 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Paulo Cancado, M.D. reported a CMS MIPS final score of 88.4/100 - above the 83.1 national average - and filed 2,123 Medicare Part D claims in 2023.
- 88.4/100
- MIPS score · +5 vs avg
- 2K
- Part D claims, 2023
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Paulo Cancado, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
88 Top 44% higher than 56% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Paulo Cancado, M.D. sits
This provider among neurology physician peers
Across the 5,437 neurology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Paulo Cancado, M.D. writes more Part D claims than 71% of them and scores higher on MIPS quality than 61% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neurology physician peer from a representative sample of 60; the gold marker is Paulo Cancado, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Paulo Cancado, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Paulo Cancado, M.D.?
High performer (top quartile)Primary specialty
Neurology Physician
Medicare Part D claims
2,123 62% vs specialty avg
MIPS final score
88.4/100 5.3 pts vs avg
Specialty distribution in Washington
How Neurology Physician compares to other specialties among Washington providers
Medicare quality performance, MIPS
Paulo Cancado, M.D.'s 2023 MIPS final score plotted against the Neurology Physician national average
- MIPS Final Score
- 88.4/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neurology Physician) - 88.4/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Paulo Cancado, M.D. appears in the CMS NPPES registry as a Neurology Physician provider holding M.D. credentials at 216 W 10TH AVE, Kennewick, WA, 99336, with a listed phone of (509) 585-5972. NPI 1902891104 was issued on 09/13/2005.
Medicare Part D records for calendar year 2023 show 2,123 prescription claims written by this provider, covering 326 Medicare beneficiaries and totaling roughly $547K in drug spend, split 5% brand-name and 93% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 88.4/100 for the 2023 performance year (Quality 89.3), compared with the national average of 83.1.
Neurology Physician is a mid-sized specialty nationwide, with 19,866 enrolled providers across 54 states and an average of 1,309 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1902891104 |
|---|---|
| Specialty | Neurology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/13/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
88.3918
Final Score
Avg: 83.1
89.2578
Quality
81
Promoting Interoperability
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Paulo Cancado, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$60
Largest payer
Alexion Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Washington WMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~34K Washington medical licensees in 2023 - they are NOT specific to Paulo Cancado, M.D.. To verify Paulo Cancado, M.D.'s current license status, search the WMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
88
Total board actions, Washington 2023
Across 85 cases
2.59
Actions per 1,000 licensees
Washington statewide rate
probation
Most common action type
31 cases
WMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Washington disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Paulo Cancado, M.D. - brand share 5.0%
Neurology Physician average
5% brand-name claims vs 93% generic, on 2,123 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,123
Total Claims
$547K
Total Drug Cost
326
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,120
- Total Day Supply
- 121,044
- Brand vs Generic
- 5% brand / 93% generic
- Brand Drug Cost
- $446K
- Generic Drug Cost
- $99K
Patient Demographics
- Average Patient Age
- 75.6 years
- Avg HCC Risk Score
- 1.30
- Gender Split
- 55% female / 45% male
- Age Distribution
- <65: 21, 65-74: 126, 75-84: 127, 85+: 52
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Paulo Cancado, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Donepezil Hcl
Donepezil Hcl
396 claims
- Gabapentin
Gabapentin
292 claims
- Memantine Hcl 137
Memantine Hcl
137 claims
- Carbidopa-Levodopa 132
Carbidopa-Levodopa
132 claims
- Lamotrigine 76
Lamotrigine
76 claims
- Pregabalin 74
Pregabalin
74 claims
- Primidone 74
Primidone
74 claims
- Levetiracetam 73
Levetiracetam
73 claims
| Drug | Claims |
|---|---|
| Donepezil Hcl | 396 |
| Gabapentin | 292 |
| Memantine Hcl | 137 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 132 |
| Lamotrigine | 76 |
| Pregabalin | 74 |
| Primidone | 74 |
| Levetiracetam | 73 |
| Galantamine Er Galantamine Hbr | 69 |
| Carbamazepine Er Carbamazepine | 57 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neurology Physician Overview
How Paulo Cancado, M.D. fits within the Neurology Physician landscape nationally.
19,866
Neurology Physician Providers in US
54
States with Neurology Physician
1,309
Avg Claims per Provider
Paulo Cancado, M.D.'s 2,123 claims are above the specialty average of 1,309.
Nearby Neurology Physician Providers in Washington
Other clinicians with the same primary specialty enrolled in Washington, drawn from the same CMS NPPES roster as Cancado.
Nandini Abburi
Seattle, WA
Dr. Tilahun Abraha
MD
Olympia, WA
Dr. Ali Abu-Alya
DO
Seattle, WA
Dr. Carlos Acevedo
MD
Walla Walla, WA
Dr. Makeda Agonafer
M.D.
Renton, WA
Compare Neurology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Washington medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neurology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Washington
Frequently Asked Questions
What is Paulo Cancado, M.D.'s specialty? ▼
Paulo Cancado, M.D. specializes in Neurology Physician and practices in Kennewick, Washington. Credentials: M.D..
How much does Paulo Cancado, M.D. prescribe under Medicare Part D? ▼
In 2023, Paulo Cancado, M.D. wrote 2,123 Medicare Part D claims totaling $547K in drug costs for 326 beneficiaries.
What is Paulo Cancado, M.D.'s Medicare quality score? ▼
Paulo Cancado, M.D. has a CMS MIPS Final Score of 88.4/100 (Quality: 89.3). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Paulo Cancado, M.D. located? ▼
Paulo Cancado, M.D. is located at 216 W 10TH AVE, Kennewick, WA, 99336. Phone: (509) 585-5972.
What is Paulo Cancado, M.D.'s NPI number? ▼
Paulo Cancado, M.D.'s National Provider Identifier (NPI) is 1902891104, issued on 09/13/2005.
Does Paulo Cancado, M.D. prescribe more brand-name or generic drugs? ▼
Paulo Cancado, M.D.'s prescribing is 5% brand-name and 93% generic drugs by claim count, with $446K in brand drug costs.
How many Neurology Physician providers are there in the US? ▼
There are 19,866 Neurology Physician providers across 54 states in the US. The average Neurology Physician provider writes 1,309 Medicare Part D claims per year.
What drugs does Paulo Cancado, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Paulo Cancado, M.D.'s most frequently prescribed drugs include Donepezil Hcl, Gabapentin, Memantine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Paulo Cancado, M.D. accept Medicare? ▼
Paulo Cancado, M.D. appears in CMS Medicare data with 2,123 Part D claims and 326 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Paulo Cancado, M.D.'s credentials? ▼
Paulo Cancado, M.D.'s NPI is 1902891104 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.